Cargando…

Pattern of clinical research in the era of COVID-19 pandemic: A new learning experience for the present as well as future

Detalles Bibliográficos
Autores principales:	Mahalmani, Vidya M., Semwal, Ankita, Kaur, Harpinder, Kaur, Sukhmeet, Prakash, Ajay, Medhi, Bikash
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722903/ https://www.ncbi.nlm.nih.gov/pubmed/33078724 http://dx.doi.org/10.4103/ijp.IJP_669_20

Ejemplares similares

COVID-19 pandemic: A review based on current evidence
por: Mahalmani, Vidya M., et al.
Publicado: (2020)

Do alternatives to animal experimentation replace preclinical research?
por: Mahalmani, Vidya, et al.
Publicado: (2023)

Translational research: Bridging the gap between preclinical and clinical research
por: Mahalmani, Vidya, et al.
Publicado: (2022)

Coronavirus Disease-2019 Pandemic: Hopes Ride High on Targeting Known Drugs against Unkown
por: Mahalmani, Vidya M., et al.
Publicado: (2020)

Role of Iron Chelators in Mucormycosis
por: Mahalmani, Vidya, et al.
Publicado: (2021)

Artificial intelligence in pharmacovigilance: Practical utility
por: Murali, Kotni, et al.
Publicado: (2019)

Positive list of antibiotics and food products: Current perspective in India and across the globe
por: Mahalmani, Vidya M., et al.
Publicado: (2019)

Antimicrobial resistance: An unseen threat prowling behind the COVID-19 outbreak
por: Mahalmani, Vidya, et al.
Publicado: (2021)

Peptides and peptidomimetics as a therapeutic candidate for the treatment of COVID-19: A brief review
por: Kumaravel, J., et al.
Publicado: (2023)

Clinically relevant cell culture models and their significance in isolation, pathogenesis, vaccine development, repurposing and screening of new drugs for SARS-CoV-2: a systematic review
por: Kumar, Subodh, et al.
Publicado: (2021)

In silico docking and comparative ADMET profile of different glycogen synthase kinase 3 beta inhibitors as the potential leads for the development of anti-Alzheimer drug therapy
por: Prajapat, Manisha, et al.
Publicado: (2020)

Ivermectin as a potential drug for treatment of COVID-19: an in-sync review with clinical and computational attributes
por: Kaur, Harpinder, et al.
Publicado: (2021)

Emerging antimicrobial resistance and newer tools to address the resistance
por: Goyal, Pardeep Kumar, et al.
Publicado: (2019)

Efficacy and safety of inhaled nitric oxide in the treatment of severe/critical COVID-19 patients: A systematic review
por: Prakash, Ajay, et al.
Publicado: (2021)

Novel therapeutic approaches toward Hantaan virus and its clinical features’ similarity with COVID-19
por: Singh, Harvinder, et al.
Publicado: (2020)

Systematic review and meta-analysis of effectiveness and safety of favipiravir in the management of novel coronavirus (COVID-19) patients
por: Prakash, Ajay, et al.
Publicado: (2020)

Regulatory approval for COVID-19 across the globe
por: Mahalmani, Vidya, et al.
Publicado: (2020)

Collaborative research in modern era: Need and challenges
por: Bansal, Seema, et al.
Publicado: (2019)

Pattern of pharmacological research from the last six decades
por: Joshi, Rupa, et al.
Publicado: (2019)

Paxlovid: A promising drug for the challenging treatment of SARS-COV-2 in the pandemic era
por: Niraj, Niraj, et al.
Publicado: (2022)

Three-dimensional drugs: A new era in the pharmaceutical development
por: Kumar, Harish, et al.
Publicado: (2017)

Genomic biomarkers: Unveiling the potential for precise cancer therapy response
por: Kaur, Gurjeet, et al.
Publicado: (2023)

Intellectual property rights and Indian pharmaceutical industry: Present scenario
por: Prakash, Ajay, et al.
Publicado: (2018)

Ayurvedic research and methodology: Present status and future strategies
por: Chauhan, Ashutosh, et al.
Publicado: (2015)

Oral Atenolol versus Propranolol in the Treatment of Infantile Hemangioma: A Systematic Review and Meta-Analysis
por: Pattanshetti, Swapnil Annasaheb, et al.
Publicado: (2022)

Indian contribution toward biomedical research and development in COVID-19: A systematic review
por: Kaur, Hardeep, et al.
Publicado: (2021)

Folic acid as placebo in controlled clinical trials of hydroxychloroquine prophylaxis in COVID-19: Is it scientifically justifiable?
por: Kaur, Hardeep, et al.
Publicado: (2021)

A Novel Inhibitor of DKK1/LRP6 Interactions Against the Alzheimer Disease: An Insilco Approach
por: Prajapat, Manisha, et al.
Publicado: (2023)

Tolerance of bladder antispasmodics in children with urinary incontinence: An observational study from North India
por: Bansal, Vishal, et al.
Publicado: (2011)

Granulocyte-colony stimulating factor improves Parkinson's disease associated with co-morbid depression: An experimental exploratory study
por: Prakash, Ajay, et al.
Publicado: (2013)

New generation vaccine: Novel approaches of vaccine design and delivery and current challenges of vaccine development
por: Bansal, Seema, et al.
Publicado: (2022)

Imaging techniques in drug development
por: Gupta, Shreya, et al.
Publicado: (2022)

Role of intravenous aspirin versus oral aspirin in the treatment of acute coronary syndrome: Answering a clinical query by systematic review and meta-analysis of randomized controlled trials
por: Kaur, Hardeep, et al.
Publicado: (2023)

Antiepileptic drugs in development pipeline: A recent update
por: Kaur, Harjeet, et al.
Publicado: (2016)

Materiovigilance Programme of India: Current status and way forward
por: Saifuddin, P. K., et al.
Publicado: (2022)

An urgent need for experimental animal model of autism in drug development
por: Ruhela, Rakesh K, et al.
Publicado: (2015)

Newer potential pharmacological targets for autism spectrum disorder
por: Jain, R. Ashish, et al.
Publicado: (2019)

Can changing the prodrug moiety in remdesivir be a life-saving strategy in COVID-19 infection?
por: Prabha, Praisy K., et al.
Publicado: (2023)

Clinical trials for food – The gray areas: Developing countries' perspective
por: Prabha, Praisy K., et al.
Publicado: (2023)

Specifically targeted antimicrobial peptides: A new and promising avenue in selective antimicrobial therapy
por: Sarma, Phulen, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_24fegsd3ncn4te1diglajujbcp